NCT04173611View on ClinicalTrials.gov

Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 8, 2020

Primary Completion Date

December 7, 2020

Study Completion Date

December 7, 2020

Conditions
Healthy
Interventions
DRUG

EXPAREL

Injection into the Intrathecal space.

DRUG

Bupivacaine Hydrochloride

Injection into the Intrathecal space.

OTHER

Placebo

Injection into the Intrathecal space.

Trial Locations (1)

27710

Duke University, Durham

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT04173611 - Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy Volunteers | Biotech Hunter | Biotech Hunter